HR-3644-119
Referred to the Committee on Education and Workforce, and in addition to the Committees on the Judiciary, Financial Services, Energy and Commerce, Transportation and Infrastructure, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by Grace Meng (D-NY)
What it does
This bill would expand access to menstrual products (such as tampons and pads) through several federal mechanisms. It would require Medicaid to cover menstrual products, create grants through TANF and the Social Services Block Grant for low-income individuals, and authorize the Emergency Food and Shelter Program to distribute them to people experiencing homelessness. It would also require free menstrual products in federal buildings open to the public, federal and state correctional and immigration detention facilities, and workplaces with 100 or more employees, and would establish grants for colleges and universities to provide them to students. Finally, it would prohibit state and local governments from imposing sales taxes on menstrual products.
Who benefits
Low-income individuals who menstruate who currently struggle to afford products, including Medicaid enrollees and TANF recipients. Incarcerated and detained individuals in federal and state facilities. Students at colleges and universities receiving grants. Employees at large employers (100+ workers). People experiencing homelessness. Elementary and secondary school students at schools using eligible grant funds. Menstrual product manufacturers and distributors who may see increased demand through federal purchasing. Retailers in states where the sales tax prohibition would reduce prices at the point of sale.
Who is hurt
State and local governments that currently collect sales tax revenue on menstrual products, which would lose that revenue under the tax prohibition — a mandate imposed without federal compensation. Large employers (100+ employees) that would bear the cost of providing free products. States that operate Medicaid programs would face new mandatory coverage requirements and associated administrative costs. Competing personal care product categories that do not receive similar federal support. Taxpayers broadly, who would fund the new grant programs and expanded Medicaid coverage.
Supporters argue
Supporters argue that menstrual products are a medical necessity, not a luxury, and that "period poverty" — the inability to afford these products — forces many low-income students, workers, and incarcerated individuals to miss school, work, or suffer health consequences. They contend that 22 states still tax menstrual products as non-essential goods, creating an inequitable financial burden on roughly half the population, and that federal programs like Medicaid already cover comparable health necessities. They argue the bill addresses a documented gap in federal health and social support programs.
Opponents argue
Opponents argue that the bill imposes unfunded mandates on states — both by prohibiting sales taxes without compensation and by adding a new mandatory Medicaid coverage category — raising serious Spending Clause concerns about federal coercion of state fiscal policy. They contend that product distribution is better handled at the state and local level, where needs and resources vary, and that the employer mandate on businesses with 100+ employees adds operating costs that may reduce wages or employment. They further argue that the sales tax prohibition sets a precedent for federal override of state tax authority over consumer goods.
Constitutional context
Congress would rely on the Taxing and Spending Clause (Art. I, §8, cl. 1) to fund grants and expand Medicaid, and the Commerce Clause (Art. I, §8, cl. 3) to impose the employer mandate and the sales tax prohibition on states. The Spending Clause coercion limit identified in NFIB v. Sebelius (2012) is relevant: conditions attached to federal funds must leave states a genuine choice, and the new mandatory Medicaid coverage requirement could face scrutiny on those grounds. The federal preemption of state and local sales taxes via the Supremacy Clause (Art. VI, cl. 2) is also a potential point of challenge.
Checks and balances
Congress would gain authority to set new mandates on states, employers, and correctional facilities; checks include judicial review of the Spending Clause coercion limits and Commerce Clause scope, as well as HHS and agency rulemaking subject to post-Loper Bright independent judicial scrutiny.
Historical precedent
Several states have independently eliminated sales taxes on menstrual products and enacted facility access laws, but no prior federal legislation has comprehensively addressed menstrual product access across Medicaid, correctional facilities, workplaces, and schools simultaneously.